Participation in Global Health Innovative Technology Fund (GHIT Fund)
GHIT Fund is a public-private partnership to support research and development of pharmaceuticals, vaccines and diagnostics for serious diseases in developing countries. It utilizes Japan’s medical technology, innovation and knowledge more directly. (https://www.ghitfund.org/)
Participation in Access Accelerated
To work on the United Nations Sustainable Development Goal to reduce premature deaths from non-communicable diseases (NCDs) by one-third by 2030, 22 leading global biopharmaceutical companies launched Access Accelerated. It is a global initiative to advance access to NCD prevention information, diagnosis and care in low and middle-income countries. (https://accessaccelerated.org/)
Participation in WFH (World Federation of Hemophilia) Humanitarian Aid Program
WFH Humanitarian Aid Program is a landmark initiative leading the effort to improve access to care and treatment for people with inherited bleeding disorders in developing countries where access to treatment is limited.